News & Updates

The association between proton pump inhibitor (PPI) use and increased cardiovascular disease risk, as seen in many observational studies, is probably caused by residual confounding related to conditions with PPI treatment instead of a true correlation, as suggested by negative findings in a self-controlled case series (SCCS) study.

The risk of psychiatric disease is higher in individuals with eosinophilic esophagitis (EoE) compared to their siblings and the general population, reveals a study. This risk must be addressed in clinical care to detect, prevent, and treat comorbidity.

The risk of recurrence after curative resection appears to be higher for stage II right-sided colon cancer, reports a recent study.

Discontinuation of proton pump inhibitor (PPI) use remains prevalent, even within a group of mostly academic gastroenterology (GI) practitioners, despite evidence suggesting the safety of long-term PPI use without routine monitoring, a study has shown.

A recent study has shown that use of aspirin can help reduce the risk of developing liver cancer.

Use of antiplatelet (AP) medication appears to increase bleeding and decompensation events among privately insured patients with cirrhosis, a study has found. Use of nonsteroidal anti-inflammatory drug (NSAID) is also associated with significant early bleeding, but not decompensations. Anticoagulants (AC), on the other hand, are not associated with bleeding or decompensation outcomes.